Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxymethylpyrimidine-binding protein (ThiY) is a specialized periplasmic binding protein primarily found in bacteria and some archaea [1, 7]. It serves as the substrate-recognition component of the ThiXYZ ATP-binding cassette (ABC) transporter system, which facilitates the uptake of hydroxymethylpyrimidine (HMP) and its precursors, such as N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine (FAMP) [7, 9]. These molecules are critical intermediates in the salvage and biosynthesis of thiamine (Vitamin B1), an essential cofactor for enzymes involved in carbohydrate and amino acid metabolism [1, 6]. Since humans do not possess the machinery to synthesize or salvage thiamine precursors in this manner, ThiY is considered a promising target for the development of narrow-spectrum or novel antimicrobial drugs [1, 3]. Targeting ThiY aims to disrupt the pathogen's thiamine supply, leading to metabolic arrest and cell death, particularly in environments where de novo thiamine synthesis is restricted [1, 11]. Research into ThiY inhibitors focuses on HMP analogs, such as CF3-HMP, that can competitively bind the protein or block the transport channel [1, 3]. The protein's structure, characterized by a typical periplasmic binding protein fold, provides a clear template for structure-based drug design [7, 9]. Overall, ThiY represents a strategic vulnerability in bacterial metabolism that can be exploited for therapeutic intervention against infectious diseases [1, 12].
Inhibition of the thiamine salvage pathway by blocking the transport of hydroxymethylpyrimidine (HMP) precursors, leading to thiamine deficiency and metabolic arrest in bacteria.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxymethylpyrimidine-binding protein (ThiY) (ThiY).